Bloomage Biotechnology (China) Today

688363 Stock   57.40  0.10  0.17%   

Performance

6 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 9

 
High
 
Low
Low
Bloomage Biotechnology is trading at 57.40 as of the 26th of November 2024, a 0.17 percent decrease since the beginning of the trading day. The stock's open price was 57.5. Bloomage Biotechnology has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for Bloomage Biotechnology Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of September 2024 and ending today, the 26th of November 2024. Click here to learn more.
Business Domain
Materials
Category
Basic Materials
Bloomage Biotechnology is entity of China. It is traded as Stock on SHG exchange. The company has 481.68 M outstanding shares. More on Bloomage Biotechnology Corp

Moving together with Bloomage Stock

  0.65601899 Zijin Mining GroupPairCorr
  0.74600309 Wanhua Chemical GroupPairCorr
  0.87600019 Baoshan Iron SteelPairCorr
  0.87002493 Rongsheng PetrochemicalPairCorr
  0.72600010 Inner Mongolia BaoTouPairCorr

Bloomage Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bloomage Biotechnology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bloomage Biotechnology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman GMYan Zhao
Thematic IdeaBiotech (View all Themes)
Business ConcentrationSpecialty Chemicals, Basic Materials, Biotech, Materials, Chemicals, Specialty Chemicals, Basic Materials (View all Sectors)
Bloomage Biotechnology's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Bloomage Biotechnology's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Bloomage Biotechnology can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Bloomage Biotechnology's financial leverage. It provides some insight into what part of Bloomage Biotechnology's total assets is financed by creditors.
Liquidity
Bloomage Biotechnology cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Bloomage Biotechnology Corp has accumulated 153.13 M in total debt. Debt can assist Bloomage Biotechnology until it has trouble settling it off, either with new capital or with free cash flow. So, Bloomage Biotechnology's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bloomage Biotechnology sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bloomage to invest in growth at high rates of return. When we think about Bloomage Biotechnology's use of debt, we should always consider it together with cash and equity.

Net Borrowings

111.74 Million
Bloomage Biotechnology Corp (688363) is traded on Shanghai Stock Exchange in China and employs 4,655 people. Bloomage Biotechnology is listed under Specialty Chemicals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 27.72 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bloomage Biotechnology's market, we take the total number of its shares issued and multiply it by Bloomage Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bloomage Biotechnology operates under Chemicals sector and is part of Materials industry. The entity has 481.68 M outstanding shares. Bloomage Biotechnology generates positive cash flow from operations, but has no cash available
Check Bloomage Biotechnology Probability Of Bankruptcy
Ownership Allocation
Bloomage Biotechnology holds a total of 481.68 Million outstanding shares. Bloomage Biotechnology Corp shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.0 percent of Bloomage Biotechnology outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bloomage Ownership Details

Bloomage Biotechnology Risk Profiles

Although Bloomage Biotechnology's alpha and beta are two of the key measurements used to evaluate Bloomage Biotechnology's performance over the market, the standard measures of volatility play an important role as well.

Bloomage Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bloomage Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

Bloomage Biotechnology Corporate Directors

Lingli LinDeputy DirectorProfile
Hui WangCFO DirectorProfile
Xueping GuoDeputy DirectorProfile
Aihua WangEx DirectorProfile

Other Information on Investing in Bloomage Stock

Bloomage Biotechnology financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology security.